Search results
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 2 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus...
Microsoft asks AI employees in China to relocate amid tensions between the U.S. and China
Quartz· 5 days agoMicrosoft is reportedly asking hundreds of its employees in China to consider relocating outside of...
Dow Jones hits record milestone as US bets on faster rate cuts
The Telegraph via Yahoo Finance· 5 days agoThe Dow Jones Industrial Average hit a record 40,000 this afternoon, seen as a major milestone for...
Stocks of local interest
Clinton Herald, Iowa via Yahoo Finance· 3 days agoMay 17—Closing prices Friday Adv Auto Parts 74.55 Abbott Labs 104.10 ADM 61.62 Ameriprise 434.12 AutoZone, Inc. 2,917.50 Boeing 184.95 Bank of America 39.29 BP PLC ADR 37.49 ConAgra Foods 30.73 ...
Shadow Trading: How Far Can the SEC Expand the Insider Trading Prohibition? | New York Law Journal
Law.com· 6 days agoIn the 1980s, federal prosecutors vastly stretched the reach of the federal mail and wire fraud...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 4 days ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
GSK Sells Last Haleon Shares for $1.58 Bln
Market Watch· 4 days agoBy Ian Walker GSK said has sold its remaining stake in Haleon for GBP1.25 billion ($1.58 billion), ending its gradual disposal of shares in the company...
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
InvestorPlace· 5 days agoIt’s no secret that artificial intelligence (AI) promises to transform every industry and sector,...
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 5 hours agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...
GSK to divest remaining 4.2% stake in Haleon
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe original consumer healthcare business was a joint venture between GSK and Pfizer, with ownership stakes of 68% and 32%, respectively. The initial...
